Skip to main content

Table 3 Trends in parasite resistance after cessation of chloroquine use in malaria

From: Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors

Author

Mean IC50 in parasites with Pfct K76T

Country where study was done

Year policy was changed

Trends in prev. of 76T CQR allele AF PC

Trends in prev. of 86Y CQR allele AF PC

Andriantsoanirina et al. [37]

18.7 nM (95% CI 14.7–23.7 nM)

Madagascar

2005

NR

NR

Achieng et al. [19]

NR

Kenya

1999

2008–2014: 28.5%, 2014: 2.3%

2008–2014: 14.9%

Hemming-Schroeder et al. [20]

NR

Kenya

1999

Kakamega

2003: 80%

2005: 61%

2008: 60%

2015: 2.7%

Kombewa

2003: 71%

2005: 91.9%

2008: 90%

2015: 11.8%

Kakamega

2003: 59.2%

2005: 59.1%

2008: 40%

2015: 4.2%

Kombewa

2003: 57.1%

2005: 40%

2008: 45%

2015: 5%

Akala et al. [46]

NR

Kenya

1999

2008: 68.4%

2009: 55.4%

2010: 47.8%

2011: 12.4%

2012: 29.8%

2008: 38.1%

2009: 24.3%

2010: 19.7%

2011: 7.8%

2012: 13.3%

Lucchi et al. [22]

2010: 31.77 nM

2011: 23.42 nM

2012: 21.09 nM

2013: 19.85 nM

Kenya

1999

2010: 38.8%

2011: 28.6%

2012: 18.7%

2013: 7%

2010: 2%

2011: 1.5%

2012: 0%

2013: 0%

Okombo et al. [18]

NR

Kenya

1999

2006: 49.5%

2013: 17.2%

2006: 57.5%

2013: 2.1%

Mwai et al. [21]

63 ± 90 nM (5-150 nM)

Kenya

1999

1993–2006: 94% to 63%

1993–2006: 75%

Bo Huang et al. [35]

NR

Grande Comore Island

2004

2006–2014: 72.2–19.5%

2006–2007: 87%

2013–2014: 40.2%

Das et al. [28]

Kolkata

2013: 238.6 nM, (95% CI 121–321 nM)

Purulia

2013: 247.42 nM, (95% CI 126–316 nM)

India

1982

Kolkata

2012: 94.64%

Purulia

2012: 96.15%

Kolkata

2013: 87.23%

2009: 46.67%

Purulia

2013: 87.93%

2009: 64.2%

Frank et al. [29]

NR

Gabon

2003

1995–2002: 100%; 2005–2007: 97%

NR

Gadalla et al. [77]

NR

Tanzania

2001

2003: 96.9%

2004: 94.9%

2005: 89.5%

2006: 100%

2003: 67.7%

2004: 67.8%

2005: 66.2%

2006: 75%

Jovel et al. [34]

NR

Guinea-Bissau

2008

2008: 31%

2010: 48%

2011: 57%

2012: 34%

2008: 36%

2010: 30%

2011: 29%

2012: 34%

Ly [30]

NR

Senegal

2003

2004–2005: 47.16%,

2006–2009: 59.46%

 

Afsharpad et al. [44]

NR

Iran

2007

2008–2010: 94.7%

2008–2010: 42.9%

Mbogo et al. [24]

NR

Uganda

2004

2005: 100%

2007: 100%

2008: 98%

2009: 94%

2010: 96%

2011: 92%

2012: 67%

2005 (53%)

2007 (49%)

2008 (16%)

2009 (44%)

2010 (19%)

2011 (16%)

2012 (8%)

Mwanza et al. [38]

NR

Zambia

2003

2001: 95%

2006: 26%

2010–2013: 0%

NR

Ndam et al. [32]

NR

Cameroon

2002

2003: 53%

2012: 25.3%

NR

Ndiaye et al. [31]

NR

Senegal

2003

2009: 19.8%

2010: 18.2%

2011: 18%

NR

Sondo et al. [79]

NR

Burkina Faso

2005

2010: 27.22%

2012: 16.49%

NR

Thomsen et al. [16]

NR

Mozambique

2002

2009: 55.9%

2010: 33.8%

2009: 47.2%

2010: 26.9%

Raman et al. [17]

NR

Mozambique

2002

2006: 96.1%

2007: 91.3%

2008: 76.1%

2009: 45.5%

2010: 32.4%

2006: 74.7%

2007: 76.4%

2008: 64.9%

2009: 51.6%

2010: 30.9%

Duah et al. [25]

NR

Ghana

2005

2005–2006:73–95%

2007–2008:50–95%, 2010: 45–80%

2005–2006:31–67%

2007–2008:36–67%

2010: 10–50%

  1. CQR chloroquine resistance, PC policy change, BF before, AF: after, NR Not reported, Prev. prevalence